pol gene diversity of five human immunodeficiency virus type 1 subtypes: evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D.
about
Conservation of functional domains and limited heterogeneity of HIV-1 reverse transcriptase gene following vertical transmissionComparable long-term efficacy of Lopinavir/Ritonavir and similar drug-resistance profiles in different HIV-1 subtypesThe challenge of HIV-1 antiretroviral resistance in Africa in the era of HAART.Use of sequence data generated in the Bayer Tru Gene genotyping assay to recognize and characterize non-subtype-b human immunodeficiency virus type 1 strainsTransmitted drug resistance in nonsubtype B HIV-1 infection.Functional conservation and coherence of HIV-1 subtype A Vpu alleles.Convergent evolution of reverse transcriptase (RT) genes of human immunodeficiency virus type 1 subtypes E and B following nucleoside analogue RT inhibitor therapies.Evolutionary relationships among parvoviruses: virus-host coevolution among autonomous primate parvoviruses and links between adeno-associated and avian parvovirusesGenotypic testing for human immunodeficiency virus type 1 drug resistance.Broad cross-clade T-cell responses to gag in individuals infected with human immunodeficiency virus type 1 non-B clades (A to G): importance of HLA anchor residue conservation.Sequence diversity of the reverse transcriptase of human immunodeficiency virus type 1 from untreated Brazilian individuals.Developing and evaluating comprehensive HIV infection control strategies: issues and challengesFrequent polymorphism at drug resistance sites in HIV-1 protease and reverse transcriptaseGenetic divergence of human immunodeficiency virus type 1 Ethiopian clade C reverse transcriptase (RT) and rapid development of resistance against nonnucleoside inhibitors of RT.In vitro intersubtype recombinants of human immunodeficiency virus type 1: comparison to recent and circulating in vivo recombinant forms.Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C.Population dynamics of HIV-1 inferred from gene sequences.Replicative fitness costs of nonnucleoside reverse transcriptase inhibitor drug resistance mutations on HIV subtype C.Testing genotypic and phenotypic resistance in human immunodeficiency virus type 1 isolates of clade B and other clades from children failing antiretroviral therapy.A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies.Cross-clade inhibition of recombinant human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus SIVcpz reverse transcriptases by RNA pseudoknot aptamers.Catalytic efficiency and vitality of HIV-1 proteases from African viral subtypes.Association between different anti-Tat antibody isotypes and HIV disease progression: data from an African cohortAnalysis of HIV-1 CRF_01 A/E protease inhibitor resistance: structural determinants for maintaining sensitivity and developing resistance to atazanavirLow-Frequency Drug Resistance in HIV-Infected Ugandans on Antiretroviral Treatment Is Associated with Regimen Failure.The Genetic Basis of HIV-1 Resistance to Reverse Transcriptase and Protease Inhibitors.Identification of sequential viral escape mutants associated with altered T-cell responses in a human immunodeficiency virus type 1-infected individual.Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals.Lack of in vivo compartmentalization among HIV-1 infected naïve and memory CD4+ T cell subsets.Analysis of selection pressure and mutational pattern of HIV type 1 reverse transcriptase region among treated and nontreated patients.Comparison of human immunodeficiency virus type 1 (HIV-1) protease mutations in HIV-1 genomes detected in plasma and in peripheral blood mononuclear cells from patients receiving combination drug therapyMutation patterns of the reverse transcriptase and protease genes in human immunodeficiency virus type 1-infected patients undergoing combination therapy: survey of 787 sequences.Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: evidence of many minor drug resistance mutations in treatment-naive patients.Resistance to human immunodeficiency virus type 1 protease inhibitors.Diminished replicative fitness of primary human immunodeficiency virus type 1 isolates harboring the K65R mutation.Reverse transcriptase backbone can alter the polymerization and RNase activities of non-nucleoside reverse transcriptase mutants K101E+G190S.Sensitivity changes over the course of infection increases the likelihood of resistance against fusion but not CCR5 receptor blockers.Genetic analysis of a UNAIDS HIV type 1 from Brazil revealed an unexpected recombination patternFunctional conservation and coherence of HIV-1 subtype A Vpu alleles
P2860
Q24814895-8E065AF5-EC0F-48BF-9078-5E546694254EQ28539169-EC80FA0A-AC18-475F-A817-7DF3F73F1991Q30425595-04D1A317-1230-41C8-83C9-9960BF905F4BQ31009699-00913886-2DF7-4169-9461-1E6121F0382DQ33567164-9789B54E-70E1-4DA5-B627-91BED7A3B90AQ33670199-D3512966-0BF9-4C5B-8A16-F3546BE33427Q33787173-A56567CB-2991-43D5-8B2C-815E2A52C5E5Q33865608-C0247F0C-A5E7-4591-A8B7-C844AF904EF6Q33906239-B2DE960D-3EC6-4B76-B26C-7F4D1C36EBEAQ33930297-49314DCC-60D3-41EF-8BCC-29D44F475D4EQ33977153-2A5B4930-69E9-497E-BD5D-2C8ECCD4689FQ34034454-00B06161-1661-45B3-9935-2C209F963F1CQ34066537-C27E69A3-B731-4060-99D2-E866D7B39A2CQ34110204-BE897087-D66D-4A05-96D7-7DB79A93FEDFQ34346614-7586AF2A-6B62-4783-834E-2B0D4BC14247Q34465489-D2A8CFD5-668A-4049-A804-C5335D5CE615Q34490344-B71A2EE1-004F-4646-88EE-611A0F004E7FQ34933329-B7407446-0391-41DA-83D8-38471C4263D4Q34989641-26A53633-4129-4C87-A8EE-6CDA6F5F3881Q35742512-FFB0DD81-FD7C-42D0-9223-D73B3FCF8470Q35857522-0B6308E8-122E-4FF1-AB65-F40B12E746DEQ35927934-E44AFD40-3A5C-439D-BF68-C0BA6F568EDDQ36083803-F36ED62E-4C8E-4D5B-B97C-C6E30CB6611DQ36841895-426DF01B-53ED-4865-AA92-78045AD7F652Q36933330-CEF48ACC-C1AA-4264-BE72-31E74053A671Q37018369-791DC9A8-EC66-4469-A57F-3324E85A03B4Q37059821-6B27C9F8-92FE-49FB-9150-EE85E68BEF0EQ37110723-08D1132B-E7B5-4868-980C-0D5D5F0B1C78Q37366730-03280AF0-9E7F-466C-8C5F-82A4E64ECA8DQ37550353-DDC0A126-A1A7-4BCD-90FA-60E56D973723Q39448983-50B65F11-076B-4B8E-BC06-EF693E5B06CDQ39454015-B96628FA-30D7-4C31-980F-8EFCAF3E190DQ39461924-2D6F84E8-11CA-4D4C-B964-D729B1C4B918Q39559316-1717BD41-0568-4673-AC22-654D20EEA7DFQ41766427-F77CC6C9-8871-4997-8046-C5DC744A4C9FQ42159090-9544E73F-0E46-4C6D-8458-6485A3DC7F69Q42348438-183CCF39-E4A8-4587-A201-27CB089DDD84Q42557274-032C863A-0A2B-4E76-A375-46F0821EBA98Q57019978-2385019F-03E9-4CE1-99BE-E132F1199169
P2860
pol gene diversity of five human immunodeficiency virus type 1 subtypes: evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
pol gene diversity of five hum ...... ancestry for subtypes B and D.
@ast
pol gene diversity of five hum ...... ancestry for subtypes B and D.
@en
type
label
pol gene diversity of five hum ...... ancestry for subtypes B and D.
@ast
pol gene diversity of five hum ...... ancestry for subtypes B and D.
@en
prefLabel
pol gene diversity of five hum ...... ancestry for subtypes B and D.
@ast
pol gene diversity of five hum ...... ancestry for subtypes B and D.
@en
P2093
P2860
P1433
P1476
pol gene diversity of five hum ...... ancestry for subtypes B and D
@en
P2093
Cornelissen M
Goudsmit J
Lukashov V
Zorgdrager F
van den Burg R
P2860
P304
P407
P577
1997-09-01T00:00:00Z